ZA9508642B - Novel carboxylicatives their preparation and use - Google Patents

Novel carboxylicatives their preparation and use

Info

Publication number
ZA9508642B
ZA9508642B ZA9508642A ZA9508642A ZA9508642B ZA 9508642 B ZA9508642 B ZA 9508642B ZA 9508642 A ZA9508642 A ZA 9508642A ZA 9508642 A ZA9508642 A ZA 9508642A ZA 9508642 B ZA9508642 B ZA 9508642B
Authority
ZA
South Africa
Prior art keywords
carboxylicatives
novel
preparation
use
Prior art date
Application number
ZA9508642A
Inventor
Hartmut Riechers
Dagmar Klinge
Wilhelm Amrberg
Andreas Kling
Stefan Mueller
Ernst Baumann
Joachim Rheinheimer
Uwe Josef Vogelbacher
Wolfgang Wernet
Liliane Unger
Manfred Raschack
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to DE4436851 priority Critical
Application filed by Basf Ag filed Critical Basf Ag
Publication of ZA9508642B publication Critical patent/ZA9508642B/en
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6530833&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA9508642(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulfur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulfur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulfur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/95Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C07D239/96Two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D251/00Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/14Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
    • C07D251/16Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
    • C07D251/20Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with no nitrogen atoms directly attached to a ring carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D251/00Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D251/00Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40Nitrogen atoms
    • C07D251/48Two nitrogen atoms
    • C07D251/52Two nitrogen atoms with an oxygen or sulfur atom attached to the third ring carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • C07D491/044Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
ZA9508642A 1994-10-14 1995-10-13 Novel carboxylicatives their preparation and use ZA9508642B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE4436851 1994-10-14

Publications (1)

Publication Number Publication Date
ZA9508642B true ZA9508642B (en) 1997-04-14

Family

ID=6530833

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9508642A ZA9508642B (en) 1994-10-14 1995-10-13 Novel carboxylicatives their preparation and use

Country Status (30)

Country Link
US (15) USRE42462E1 (en)
EP (2) EP1110952B9 (en)
JP (6) JP3957748B2 (en)
KR (1) KR100438339B1 (en)
CN (3) CN1923820B (en)
AT (2) AT277911T (en)
BR (1) BR9509338A (en)
CA (1) CA2201785C (en)
CZ (1) CZ294603B6 (en)
DE (4) DE19533023B4 (en)
DK (1) DK0785926T3 (en)
ES (2) ES2162942T3 (en)
FI (1) FI120492B (en)
GR (1) GR3036931T3 (en)
HK (2) HK1066541A1 (en)
HR (2) HRP950517B1 (en)
HU (1) HU220621B1 (en)
IL (1) IL115560A (en)
LU (1) LU91487I2 (en)
MX (1) MX9702658A (en)
NL (1) NL300361I2 (en)
NO (2) NO308846B1 (en)
NZ (1) NZ294849A (en)
PL (1) PL186850B1 (en)
PT (1) PT785926E (en)
RU (1) RU2180335C2 (en)
SI (1) SI9520110A (en)
TW (1) TW577880B (en)
WO (1) WO1996011914A1 (en)
ZA (1) ZA9508642B (en)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19533023B4 (en) * 1994-10-14 2007-05-16 Basf Ag New carboxylic acid derivatives, their preparation and use
DE19536891A1 (en) * 1995-10-04 1997-04-10 Basf Ag New amino acid derivatives, their preparation and use
DE19614534A1 (en) * 1996-04-12 1997-10-16 Basf Ag New carboxylic acid derivatives, their preparation and use
DE19614533A1 (en) * 1996-04-12 1997-10-16 Basf Ag New alpha-hydroxy-acid derivatives, their preparation and use
DE19636046A1 (en) * 1996-09-05 1998-03-12 Basf Ag New carboxylic acid derivatives, their preparation and use as mixed ET¶A¶ / ET¶B¶ receptor antagonists
EP0946524A1 (en) * 1996-12-18 1999-10-06 Basf Aktiengesellschaft Heterocyclic carboxylic acid derivatives, the production and use thereof as endothelin receptor antagonists
US6030975A (en) * 1997-03-14 2000-02-29 Basf Aktiengesellschaft Carboxylic acid derivatives, their preparation and use in treating cancer
NZ502660A (en) * 1997-09-04 2002-02-01 Basf Ag Pyrimidyl- or (oxazolyl- or thiazolyl-)oxy substituted carboxylic acid derivatives useful as mixed ETA/ETB endothelin-receptor antagonists
AU750755B2 (en) * 1997-09-26 2002-07-25 Abbvie Deutschland Gmbh & Co Kg Endothelin antagonist and a renin-angiotensin system inhibitor as a combined preparation
DE19743143A1 (en) * 1997-09-30 1999-04-01 Knoll Ag Pharmaceutical combination preparations
DE19743142A1 (en) * 1997-09-30 1999-04-01 Knoll Ag Pharmaceutical combination preparations
DE19743681A1 (en) * 1997-10-02 1999-04-08 Knoll Ag Use of endothelin receptor antagonists to prevent transplant rejection
JP2001521927A (en) * 1997-10-31 2001-11-13 ビーエーエスエフ アクチェンゲゼルシャフト Novel carboxylic acid derivatives having amide side chains, use as their preparation and endothelin receptor antagonists
DE19750529A1 (en) * 1997-11-14 1999-05-20 Basf Ag New heterocyclic alpha-hydroxycarboxylic acid derivatives useful for treating hypertension, chronic coronary insufficiency, asthma, prostate cancer etc.
DE19806438A1 (en) * 1998-02-17 1999-08-19 Basf Ag New pyrimidinyloxy-propionic acid derivatives useful as endothelin receptor antagonists in treatment of e.g. cardiac insufficiency, restenosis, hypertension, kidney failure, asthma and prostate cancer
DE19809635A1 (en) 1998-03-06 1999-09-09 Basf Ag A process for the preparation of endothelin receptor antagonists of Sulfanyltyp
DE19850301A1 (en) 1998-10-30 2000-05-04 Basf Ag A process for the resolution of 2-hydroxypropionic acids
US7566452B1 (en) 1999-05-04 2009-07-28 New York University Cancer treatment with endothelin receptor antagonists
DE10002393A1 (en) 2000-01-20 2001-07-26 Basf Ag Preparation of 3,3-diphenyl-2,3-epoxy-propionate esters from 3-phenyl-cinnamic acid esters, using method which is suitable for industrial scaling and gives high enantiomeric purity
US8168616B1 (en) 2000-11-17 2012-05-01 Novartis Ag Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
DE10064797A1 (en) * 2000-12-22 2002-06-27 Knoll Ag Combination pack useful for the treatment of e.g. deep vein thrombosis and post-operative thrombosis, containing oral and parenteral formulations of thrombin inhibitor prodrugs
WO2002064573A1 (en) * 2001-02-14 2002-08-22 Abbott Gmbh & Co. Kg Novel carboxylic acid derivatives containing alkyl substituted triazines, production of the same and use thereof as endothelin receptor antagonists
PT1243262E (en) 2001-03-20 2006-10-31 Sanol Arznei Schwarz Gmbh New use of a class of peptide compounds for the treatment of non-neuropathic inflammatory pain
AT228358T (en) 2001-03-21 2002-12-15 Sanol Arznei Schwarz Gmbh New use of a class of peptide compounds for treatment of allodynia, or other types of chronic or phantom pain
US6772708B2 (en) * 2001-10-30 2004-08-10 The Procter And Gamble Company Wetness indicator having improved colorant retention
DE10259382A1 (en) * 2002-12-18 2004-07-01 Abbott Gmbh & Co. Kg 3-Substituted 3,4-dihydro-thieno [2,3-d] pyrimidin-4-one derivatives, their preparation and use
US20040204422A1 (en) * 2003-04-14 2004-10-14 Abbott Gmbh & Co. Kg. N-[(Piperazinyl)hetaryl]arylsulfonamide compounds
GB0327839D0 (en) 2003-12-01 2003-12-31 Novartis Ag Organic compounds
US20080161321A1 (en) 2004-03-17 2008-07-03 David Louis Feldman Use of Renin Inhibitors in Therapy
KR20070007931A (en) 2004-04-16 2007-01-16 쉬바르츠파르마에이지 Use of peptidic compounds for the prophylaxis and treatment of chronic headache
EP1604656A1 (en) 2004-06-09 2005-12-14 Schwarz Pharma Ag Novel use of peptide compounds for treating amyotrophic lateral sclerosis (ALS)
PL1781276T3 (en) 2004-08-27 2010-11-30 Ucb Pharma Gmbh Use of peptide compounds for treating bone cancer pain, chemotherapy- and nucleoside-induced pain
DE102005025161A1 (en) * 2005-06-01 2006-12-07 Phenion Gmbh & Co. Kg New pyrimidine- and triazine derivatives are peroxisome proliferator activated receptor modulators, useful to treat e.g. diabetes, insulin resistance, obesity, hyperlipidemia, cardiovascular diseases and Alzheimer's disease
CA2637897A1 (en) * 2006-01-20 2007-07-26 Schering Corporation Carbocyclic and heterocyclic arylsulfones as gamma secretase inhibitors
BRPI0709950A2 (en) * 2006-04-13 2011-08-02 Actelion Pharmaceuticals Ltd use of bosentan in the preparation of a drug for the treatment of early idiopathic pulmonary fibrosis and use of endothelin receptor antagonist
DK2462990T3 (en) 2006-06-15 2014-02-17 Ucb Pharma Gmbh Pharmaceutical composition comprehensive lacosamide and levetiracetam with synergistic anti-convulsive effect
WO2008073928A1 (en) 2006-12-12 2008-06-19 Gilead Colorado, Inc. Composition for treating a pulmonary hypertension
EP2118073A2 (en) 2007-02-02 2009-11-18 Concert Pharmaceuticals Inc. Selective endothelin type-a antagonists
EP2183223A2 (en) * 2007-07-31 2010-05-12 Gilead Colorado, Inc. Metabolites and derivatives of ambrisentan
US20090069353A1 (en) * 2007-09-12 2009-03-12 Protia, Llc Deuterium-enriched ambrisentan
DE102008037324A1 (en) 2008-08-11 2010-02-18 Ratiopharm Gmbh Pharmaceutical formulation for pulmonary reduction of blood pressure
EP2350024A4 (en) * 2008-11-05 2012-03-21 Msn Lab Ltd Improved process for the preparation of endothelin receptor antagonists
WO2010091877A2 (en) 2009-02-13 2010-08-19 Ratiopharm Gmbh Process for producing ambrisentan
ES2575000T3 (en) 2009-07-10 2016-06-23 Cadila Healthcare Limited Improved process for the preparation of ambrisentane
DE202009009917U1 (en) 2009-07-21 2010-02-11 Ratiopharm Gmbh Ambrisentan in specific crystalline form
WO2011022694A2 (en) * 2009-08-20 2011-02-24 University Of Tennessee Research Foundation, The Furanopyrimidine cannabinoid compounds and related methods of use
US9018411B2 (en) 2009-12-07 2015-04-28 Cardioxyl Pharmaceuticals, Inc. Bis-acylated hydroxylamine derivatives
CN102753520B (en) * 2009-12-07 2016-06-08 约翰斯霍普金斯大学 N-acyloxy sulfonamide and N-hydroxy-n-acyl sulfonamides derivant
WO2011114338A1 (en) 2010-03-15 2011-09-22 Natco Pharma Limited A process for the preparation of highly pure ambrisentan
US20130184490A1 (en) * 2010-08-04 2013-07-18 Natco Pharma Limited Process to prepare s-2-hydroxy-3-methoxy-3,3-diphenyl propionic acid
HUE033346T2 (en) 2010-10-15 2017-11-28 Gilead Sciences Inc Compositions and methods of treating pulmonary hypertension
EP2476670A1 (en) 2011-01-07 2012-07-18 Zentiva, K.S. Stable solid salts of ambrisentan
CN102276536B (en) * 2011-06-10 2015-04-29 中国科学院化学研究所 Preparation method of optically pure (+)-ambrisentan and optically pure (+)-darusentan
CN103012280B (en) * 2011-09-22 2015-04-29 江苏康缘药业股份有限公司 Method for preparing ambrisentan
KR101855506B1 (en) 2011-10-13 2018-05-08 주식회사 동진쎄미켐 Polymer having aromatic ring and under-layer composition of resist including the same
AU2012324612A1 (en) 2011-10-19 2014-05-15 Cipla Limited Process for the preparation of an endothelin receptor antagonist
RS55345B1 (en) 2012-06-29 2017-03-31 Kern Pharma S L Preparation process of carboxylic acid derivatives and intermediates thereof
CN103524424A (en) * 2012-07-04 2014-01-22 天津药物研究院 Crystal form VI of ambrisentan as well as preparation method and application thereof
CN103524425A (en) * 2012-07-04 2014-01-22 天津药物研究院 Crystal form V of ambrisentan as well as preparation method and application thereof
CN104098462B (en) * 2013-04-12 2017-11-17 江苏豪森药业集团有限公司 The method for splitting of the diphenyl-propionic acid racemoid of 2 hydroxyl, 3 methoxyl group 3,3
CN104592129B (en) * 2013-10-30 2019-04-16 武汉启瑞药业有限公司 A kind of improved method for preparing ambrisentan
CN103709106A (en) * 2013-12-06 2014-04-09 石家庄博策生物科技有限公司 Stereoselectivity preparation method for Letairis
CN104744231A (en) * 2013-12-26 2015-07-01 天津药物研究院 Method for splitting 2-hydracrylicacid racemate
CN105801404B (en) * 2014-12-31 2019-01-08 辽宁远大诺康生物制药有限公司 A kind of S-2- hydroxy-3-methoxy -3,3- diphenyl-propionic acid and preparation method thereof
CN106699626B (en) * 2015-11-13 2019-08-16 辽宁远大诺康生物制药有限公司 A kind of preparation method of 2- hydroxy-3-methoxy -3,3- diphenylprop hydrochlorate raceme

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE403578C (en) 1924-10-02 Walter Beige A method for internal enamelling of tubes
JPS5729445B2 (en) 1974-06-25 1982-06-23
JP2771604B2 (en) * 1988-06-20 1998-07-02 イハラケミカル工業株式会社 Herbicides and novel alkanoic acid derivatives as the active ingredient thereof
DE68914197D1 (en) * 1988-06-20 1994-05-05 Kumiai Chemical Industry Co Alkanoic acid derivatives and herbicides.
GB8912700D0 (en) 1989-06-02 1989-07-19 Shell Int Research Herbicidal compounds
JPH0331266A (en) 1989-06-27 1991-02-12 Nissan Chem Ind Ltd Pyrimidine derivative and herbicide
IL94999A (en) 1989-07-19 1994-10-07 Schering Ag alpha-pyrimidinyloxy (thio)- and alpha-triazinylo xy (thio) carboxylic acid derivatives and herbici dal compositions containing the same
US5270289A (en) 1989-07-19 1993-12-14 Schering Aktiengesellschaft Herbicidal dimethoxy pyrimidinyloxy-fluorinated acids and salts
FR2650365B1 (en) 1989-07-28 1991-11-22 Caillau Ets Quick coupling
JPH03240777A (en) 1990-02-20 1991-10-28 Ube Ind Ltd Fatty acid derivative, production thereof and herbicide
DE4029648A1 (en) 1990-09-19 1992-03-26 Hoechst Ag 4-anilino-pyrimidines, process for their manufacture, compositions containing them and their use as fungicides
CA2053603A1 (en) 1990-10-19 1992-04-20 Katsumasa Harada 3-alkoxyalkanoic acid derivative, process for preparing the same and herbicide using the same
JPH05125058A (en) * 1990-10-19 1993-05-21 Ube Ind Ltd 3-alkoxyalkanoic acid compound, its intermediate and production thereof, and herbicide
DE4035758A1 (en) 1990-11-08 1992-05-14 Schering Ag New alpha-pyrimidinyl:oxy(thio) and alpha-triazinyl:oxy(thio) carboxylic acids - used as herbicides, fungicides and as plant growth regulators
JP2730021B2 (en) 1991-05-31 1998-03-25 宇部興産株式会社 3-benzyloxy-alkanoic acid derivative, its preparation and herbicides
JP2730022B2 (en) * 1991-06-07 1998-03-25 宇部興産株式会社 3-alkoxy butyryl imidazole derivatives, their preparation and herbicides
DE69226813T2 (en) * 1991-06-07 1999-02-18 Ube Industries Pyrimidine or triazine derivatives, processes for their preparation and herbicides containing
DE4123469A1 (en) 1991-07-16 1993-01-21 Basf Ag Herbicidal compsns. contg. safener - comprising N-di:chloro-acetyl-di:aza-cycloalkane deriv.
WO1993012094A1 (en) * 1991-12-10 1993-06-24 Hoechst Schering Agrevo Gmbh Pyrimidinyl- or triazinyl-oxy(or thio)aldehyde derivatives and their use as herbicides or plant-growth regulators
DE4142570A1 (en) 1991-12-21 1993-06-24 Basf Ag Glycolaldehyde and milk acid derivatives, their preparation and use
DE4201875A1 (en) 1992-01-24 1993-07-29 Basf Ag Thiocarbonsaeurederivate, processes and intermediate products for their manufacture
US5376620A (en) 1992-04-17 1994-12-27 Ube Industries, Ltd. Sulfonamide derivative, process for preparing the same and herbicide using the same
CA2110500A1 (en) * 1992-06-17 1993-12-23 Christoph Luthy Pyrimidinyl- and tetrazinyl compounds with herbicidal activity
AU4562093A (en) 1992-07-08 1994-01-31 Ciba-Geigy Ag Selective herbicidal composition
US5541148A (en) 1992-07-08 1996-07-30 Ciba-Geigy Corporation Selective safened herbicidal composition comprising 2-ethoxycarbonyl-3-(4,6-dimethoxypyrimidine-2-yl) oxy-pyridine and an acylsulfamoylphenyl-urea safener
JP2985992B2 (en) 1992-07-21 1999-12-06 宇部興産株式会社 3-alkoxy -n- cycloalkylsulfonyl alkanoic acid amide derivatives, their preparation and herbicides
DE4313412A1 (en) 1993-04-23 1994-10-27 Basf Ag 3- (Het) aryl-carboxylic acid derivatives, processes and intermediates for their preparation
DE4313413A1 (en) * 1993-04-23 1994-10-27 Basf Ag 3- (Het) aryloxy (thio) carboxylic acid derivatives, processes and intermediates for their preparation
EP0627472B1 (en) * 1993-06-03 2000-03-08 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Curable composition
DE4335950A1 (en) 1993-10-21 1995-04-27 Basf Ag Derivatives of 3-hydroxycarboxylic acids, their preparation and use
DE4411225A1 (en) 1994-03-31 1995-10-05 Basf Ag Use of carboxylic acid derivatives as a drug
AU2882195A (en) 1994-06-27 1996-01-19 Ciba-Geigy Ag Pyrimidinyl- and triazinyl-oxy and thio-3-haloalkyl-propionic acid derivatives as herbicides
DE19533023B4 (en) 1994-10-14 2007-05-16 Basf Ag New carboxylic acid derivatives, their preparation and use
DE69529581D1 (en) 1994-10-21 2003-03-13 Smithkline Beecham Corp thereof excipients for a powder inhaler as well as process for the preparation of
US6030975A (en) 1997-03-14 2000-02-29 Basf Aktiengesellschaft Carboxylic acid derivatives, their preparation and use in treating cancer
AU750755B2 (en) 1997-09-26 2002-07-25 Abbvie Deutschland Gmbh & Co Kg Endothelin antagonist and a renin-angiotensin system inhibitor as a combined preparation
DE19743143A1 (en) 1997-09-30 1999-04-01 Knoll Ag Pharmaceutical combination preparations
DE19754082A1 (en) 1997-12-05 1999-06-10 Knoll Ag Method of combating obesity
DE19850301A1 (en) 1998-10-30 2000-05-04 Basf Ag A process for the resolution of 2-hydroxypropionic acids
DE10002393A1 (en) 2000-01-20 2001-07-26 Basf Ag Preparation of 3,3-diphenyl-2,3-epoxy-propionate esters from 3-phenyl-cinnamic acid esters, using method which is suitable for industrial scaling and gives high enantiomeric purity
EP1946502B2 (en) 2006-07-12 2017-09-13 Huawei Technologies Co., Ltd. Method for controlling congestion
EP2183223A2 (en) 2007-07-31 2010-05-12 Gilead Colorado, Inc. Metabolites and derivatives of ambrisentan

Also Published As

Publication number Publication date
DK785926T3 (en)
AU688611B2 (en) 1998-03-12
IL115560D0 (en) 1996-01-19
US20060160808A1 (en) 2006-07-20
US20060276474A1 (en) 2006-12-07
EP1110952B9 (en) 2004-12-15
IL115560A (en) 2003-02-12
TW577880B (en) 2004-03-01
JP4512105B2 (en) 2010-07-28
NZ294849A (en) 1999-04-29
JP5160797B2 (en) 2013-03-13
PL319655A1 (en) 1997-08-18
DE122008000049I1 (en) 2009-01-29
JP5700378B2 (en) 2015-04-15
US6600043B2 (en) 2003-07-29
JP2007169295A (en) 2007-07-05
JP2007126488A (en) 2007-05-24
US7109205B2 (en) 2006-09-19
DK0785926T3 (en) 2001-10-08
CN1923820A (en) 2007-03-07
FI120492B1 (en)
US8349843B2 (en) 2013-01-08
NL300361I1 (en) 2008-12-01
NO2008015I1 (en) 2008-11-03
US20130317044A1 (en) 2013-11-28
AU3804595A (en) 1996-05-06
JP4512106B2 (en) 2010-07-28
SI9520110A (en) 1997-12-31
US20070203338A1 (en) 2007-08-30
HK1066541A1 (en) 2007-06-01
HRP20040364B1 (en) 2006-09-30
HUT77443A (en) 1998-04-28
PT785926E (en) 2002-02-28
FI971529D0 (en)
LU91487I2 (en) 2008-12-15
NL300361I2 (en) 2009-02-02
US6197958B1 (en) 2001-03-06
KR100438339B1 (en) 2004-08-25
CZ113297A3 (en) 1998-03-18
US7601730B2 (en) 2009-10-13
CN1160396A (en) 1997-09-24
NO2008015I2 (en) 2012-03-05
RU2180335C2 (en) 2002-03-10
CN1923820B (en) 2010-04-21
HRP20040364A2 (en) 2005-06-30
JP4787184B2 (en) 2011-10-05
NO971675D0 (en) 1997-04-11
CN1142918C (en) 2004-03-24
HRP950517A2 (en) 1997-10-31
CZ294603B6 (en) 2005-02-16
US7863445B2 (en) 2011-01-04
US7119097B2 (en) 2006-10-10
CA2201785A1 (en) 1996-04-25
GR3036931T3 (en) 2002-01-31
EP1110952B1 (en) 2004-09-29
AT204568T (en) 2001-09-15
DE59509541D1 (en) 2001-09-27
US20020052495A1 (en) 2002-05-02
JP2007137893A (en) 2007-06-07
LU91487A9 (en)
DE59510949D1 (en) 2004-11-04
US5932730A (en) 1999-08-03
US20100076188A1 (en) 2010-03-25
DE19533023A1 (en) 1996-04-18
FI971529A0 (en) 1997-04-11
EP0785926A1 (en) 1997-07-30
EP1110952A1 (en) 2001-06-27
JP2007137892A (en) 2007-06-07
AT277911T (en) 2004-10-15
CN1513844A (en) 2004-07-21
JPH10507190A (en) 1998-07-14
USRE42462E1 (en) 2011-06-14
WO1996011914A1 (en) 1996-04-25
US20120088911A1 (en) 2012-04-12
NO308846B1 (en) 2000-11-06
PL186850B1 (en) 2004-03-31
US20040092742A1 (en) 2004-05-13
KR977007103A (en) 1997-12-01
BR9509338A (en) 1997-11-04
US5969134A (en) 1999-10-19
JP3957748B2 (en) 2007-08-15
HK1104293A1 (en) 2010-12-10
HU220621B1 (en) 2002-03-28
ES2162942T3 (en) 2002-01-16
NO971675L (en) 1997-06-10
CA2201785C (en) 2006-08-29
HRP950517B1 (en) 2004-06-30
US20110178294A1 (en) 2011-07-21
MX9702658A (en) 1997-06-28
CN1293059C (en) 2007-01-03
US7582647B2 (en) 2009-09-01
FI120492B (en) 2009-11-13
DE19533023B4 (en) 2007-05-16
USRE42477E1 (en) 2011-06-21
JP2012111772A (en) 2012-06-14
EP0785926B1 (en) 2001-08-22
FI971529A (en) 1997-04-11
ES2226996T3 (en) 2005-04-01
US20060276645A1 (en) 2006-12-07

Similar Documents

Publication Publication Date Title
EG20536A (en) Compositions and use thereof
GB2298422B (en) Compounds and their use
HRP970349A2 (en) Sulfonamides and their use
ZA9504972B (en) Novel thrombin inhibitors the preparation and use thereof
PH27053A (en) Pesticidal-2-cyano-5-alkoxy-1-arylpyrazoles compositions and use
ZA9307081B (en) Azaquinoxalines processes for their preparation and their use
IL99081D0 (en) Oxime-carbamates and oxime-carbonates
HK1038365A1 (en) L-ribavirin and uses thereof
HRP960365B1 (en) New medicaments and the use thereof
IL115239D0 (en) Dentifrice compositions and their preparation
EP1021185A4 (en) Didhydropyrimidines and uses thereof
EP0751765A4 (en) Sulfonamide derivatives and their use
IL116853A (en) Metallocene compounds their preparation and use
HK1023571A1 (en) Thienotriazolodiazepine compounds and medicinal use thereof
IL122428D0 (en) Minizymes and minribozymes and uses thereof
GB9414925D0 (en) Electrode and preparation thereof
IL123147A (en) Benzimidazole-4-carboxamide derivatives and their use
IL112539D0 (en) Pyrimidine derivatives and their preparation
GB9415125D0 (en) Surgical product and its use
AT339503T (en) Cardiotrophine and use thereof
NZ315634A (en) Halobenzimidazoles and their use as microbicides
GB8907298D0 (en) Composition and use
IL120016D0 (en) Heteroatom-containing cyclopentanopyridyl-oxazolidinones their preparation and use
AU5752398A (en) Novel ketobenzamides and their use
SI0885220T1 (en) Tropane-derivatives, their preparation and use